Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
FDA Authorizes Covid Vaccine for Kids 5 and Under
03:43pm, Friday, 17'th Jun 2022
Covid-19 vaccines for children ages 5 and under from Pfizer Inc. and Moderna Inc. received authorization from US regulators, meaning almost all the American population can soon get pandemic protection
Moderna, Pfizer stocks edge higher after FDA authorizes COVID vaccines for kids
11:05am, Friday, 17'th Jun 2022
Yahoo Finance Live's Brian Sozzi reports that the FDA has authorized Moderna and Pfizer COVID vaccines for children under the age of 5.
FDA Approves COVID Vaccines for Kids as Young as 6 Months Old
10:52am, Friday, 17'th Jun 2022
Pending the CDC's signoff, both Moderna and Pfizer shots could be available for the youngest children within days.
FDA clears Pfizer, Moderna Covid vaccines for young children
10:13am, Friday, 17'th Jun 2022
The U.S. FDA has authorized Moderna's and Pfizer's Covid-19 vaccines for kids as young as 6 months. CNBC's Meg Tirrell joins 'Squawk on the Street' with the details.
FDA authorizes Pfizer and Moderna COVID-19 vaccines for children as young as 6 months old
09:45am, Friday, 17'th Jun 2022
The vaccines will be available for young children once the CDC recommends them, which will likely happen this weekend.
FDA authorizes both mRNA vaccines for young children
09:25am, Friday, 17'th Jun 2022
The Food and Drug Administration announced Friday that it authorized the COVID-19 vaccines developed by BioNTech SE BNTX, -6.41% /Pfizer Inc. PFE, -2.12% and Moderna Inc. MRNA, -5.80% for children as
FDA authorizes Pfizer and Moderna's Covid vaccines for children as young as 6 months
09:19am, Friday, 17'th Jun 2022
The White House expects vaccinations to begin as soon as Tuesday.
FDA clears COVID-19 vaccines for children under 5
09:19am, Friday, 17'th Jun 2022
The U.S. Food and Drug Administration has authorized user of the COVID-19 vaccines from Pfizer and BioNTech, and from Moderna, for kids between 6 months and 5 years of age. The FDA's decision follows
Buy BioNTech SE at the low PE of 2.31
04:46pm, Thursday, 16'th Jun 2022
BioNTech SE (NASDAQ:BNTX) is trading at $137.99. The 52-week range has been $121 to $464.
Why Pfizer, BioNTech, and Moderna Stocks Are Sinking Today
11:48am, Thursday, 16'th Jun 2022
Blame it on the overall stock market sell-off.
FDA Panel Recommends Pfizer & Moderna COVID Jabs for Young Kids
10:50am, Thursday, 16'th Jun 2022
The FDA VRBPAC committee unanimously recommends the approval of both Pfizer and BioNTech and Moderna's vaccines for young children, saying the benefits of the vaccines outweigh the risks.
Pfizer, BioNTech's COVID Jab Safe in Young Kids Per FDA
10:32am, Monday, 13'th Jun 2022
Per the FDA reviewers, the available data supports Pfizer (PFE) and BioNTech (BNTX) vaccine's effectiveness in preventing COVID infection in kids six months to under five years of age as a three-dose
Is This Downtrodden Stock a Value Trap?
08:00am, Monday, 13'th Jun 2022
Probably yes, but it could still be a good purchase for investors with the right mindset.
100 Billion Reasons to Like This Dominant Healthcare Stock
07:00am, Monday, 06'th Jun 2022
This mega-cap stock will become the first in the pharmaceutical industry to reach a major sales milestone.
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
05:43am, Sunday, 05'th Jun 2022
These were the industry's bestsellers last year, but how long can they stay on top?
